324 related articles for article (PubMed ID: 30813945)
21. Taking the risk. A systematic review of ethical reasons and moral arguments in the clinical use of polygenic risk scores.
Andreoli L; Peeters H; Van Steen K; Dierickx K
Am J Med Genet A; 2024 Jul; 194(7):e63584. PubMed ID: 38450933
[TBL] [Abstract][Full Text] [Related]
22. A polygenic p factor for major psychiatric disorders.
Selzam S; Coleman JRI; Caspi A; Moffitt TE; Plomin R
Transl Psychiatry; 2018 Oct; 8(1):205. PubMed ID: 30279410
[TBL] [Abstract][Full Text] [Related]
23. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap.
Gandal MJ; Haney JR; Parikshak NN; Leppa V; Ramaswami G; Hartl C; Schork AJ; Appadurai V; Buil A; Werge TM; Liu C; White KP; ; ; ; Horvath S; Geschwind DH
Science; 2018 Feb; 359(6376):693-697. PubMed ID: 29439242
[TBL] [Abstract][Full Text] [Related]
24. Polygenic risk score: use in migraine research.
Chalmer MA; Esserlind AL; Olesen J; Hansen TF
J Headache Pain; 2018 Apr; 19(1):29. PubMed ID: 29623444
[TBL] [Abstract][Full Text] [Related]
25. Polygenic risk scores in imaging genetics: Usefulness and applications.
Dima D; Breen G
J Psychopharmacol; 2015 Aug; 29(8):867-71. PubMed ID: 25944849
[TBL] [Abstract][Full Text] [Related]
26. Psychosocial implications of living with familial risk of a psychiatric disorder and attitudes to psychiatric genetic testing: A systematic review of the literature.
Meiser B; Guo XY; Putt S; Fullerton JM; Schofield PR; Mitchell PB; Yanes T
Am J Med Genet B Neuropsychiatr Genet; 2020 Jul; 183(5):277-288. PubMed ID: 32369270
[TBL] [Abstract][Full Text] [Related]
27. Implications of the use of genetic tests in psychiatry, with a focus on major depressive disorder: a review.
Wilde A; Mitchell PB; Meiser B; Schofield PR
Depress Anxiety; 2013 Mar; 30(3):267-75. PubMed ID: 22987566
[TBL] [Abstract][Full Text] [Related]
28. Barriers to genetic testing in clinical psychiatry and ways to overcome them: from clinicians' attitudes to sociocultural differences between patients across the globe.
Pinzón-Espinosa J; van der Horst M; Zinkstok J; Austin J; Aalfs C; Batalla A; Sullivan P; Vorstman J; Luykx JJ
Transl Psychiatry; 2022 Oct; 12(1):442. PubMed ID: 36220808
[TBL] [Abstract][Full Text] [Related]
29. The right not to know: the case of psychiatric disorders.
Bortolotti L; Widdows H
J Med Ethics; 2011 Nov; 37(11):673-6. PubMed ID: 21659442
[TBL] [Abstract][Full Text] [Related]
30. Ethical issues in psychiatric genetics.
Appelbaum PS
J Psychiatr Pract; 2004 Nov; 10(6):343-51. PubMed ID: 15583515
[TBL] [Abstract][Full Text] [Related]
31. New insights from the last decade of research in psychiatric genetics: discoveries, challenges and clinical implications.
Andreassen OA; Hindley GFL; Frei O; Smeland OB
World Psychiatry; 2023 Feb; 22(1):4-24. PubMed ID: 36640404
[TBL] [Abstract][Full Text] [Related]
32. Design and user experience testing of a polygenic score report: a qualitative study of prospective users.
Brockman DG; Petronio L; Dron JS; Kwon BC; Vosburg T; Nip L; Tang A; O'Reilly M; Lennon N; Wong B; Ng K; Huang KH; Fahed AC; Khera AV
BMC Med Genomics; 2021 Oct; 14(1):238. PubMed ID: 34598685
[TBL] [Abstract][Full Text] [Related]
33. Predictive Psychiatric Genetic Testing in Minors: An Exploration of the Non-Medical Benefits.
Manzini A; Vears DF
J Bioeth Inq; 2018 Mar; 15(1):111-120. PubMed ID: 29230699
[TBL] [Abstract][Full Text] [Related]
34. Ethical considerations in psychiatric genetics.
Hoop JG
Harv Rev Psychiatry; 2008; 16(6):322-38. PubMed ID: 19085387
[TBL] [Abstract][Full Text] [Related]
35. Common Polygenic Variations for Psychiatric Disorders and Cognition in Relation to Brain Morphology in the General Pediatric Population.
Alemany S; Jansen PR; Muetzel RL; Marques N; El Marroun H; Jaddoe VWV; Polderman TJC; Tiemeier H; Posthuma D; White T
J Am Acad Child Adolesc Psychiatry; 2019 Jun; 58(6):600-607. PubMed ID: 30768412
[TBL] [Abstract][Full Text] [Related]
36. Anticipating the Ethical Challenges of Psychiatric Genetic Testing.
Appelbaum PS; Benston S
Curr Psychiatry Rep; 2017 Jul; 19(7):39. PubMed ID: 28534296
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of the polygenic LDL-C SNP score in familial hypercholesterolemia.
Futema M; Bourbon M; Williams M; Humphries SE
Atherosclerosis; 2018 Oct; 277():457-463. PubMed ID: 30270085
[TBL] [Abstract][Full Text] [Related]
38. Posttraumatic stress disorder symptom severity is associated with reduced default mode network connectivity in individuals with elevated genetic risk for psychopathology.
Miller DR; Logue MW; Wolf EJ; Maniates H; Robinson ME; Hayes JP; Stone A; Schichman S; McGlinchey RE; Milberg WP; Miller MW
Depress Anxiety; 2017 Jul; 34(7):632-640. PubMed ID: 28494120
[TBL] [Abstract][Full Text] [Related]
39. Use of schizophrenia and bipolar disorder polygenic risk scores to identify psychotic disorders.
Calafato MS; Thygesen JH; Ranlund S; Zartaloudi E; Cahn W; Crespo-Facorro B; Díez-Revuelta Á; Di Forti M; ; Hall MH; Iyegbe C; Jablensky A; Kahn R; Kalaydjieva L; Kravariti E; Lin K; McDonald C; McIntosh AM; McQuillin A; Picchioni M; Rujescu D; Shaikh M; Toulopoulou T; Os JV; Vassos E; Walshe M; Powell J; Lewis CM; Murray RM; Bramon E
Br J Psychiatry; 2018 Sep; 213(3):535-541. PubMed ID: 30113282
[TBL] [Abstract][Full Text] [Related]
40. Polygenic heterogeneity: a complex model of genetic inheritance in psychiatric disorders.
Rucker JJ; McGuffin P
Biol Psychiatry; 2010 Aug; 68(4):312-3. PubMed ID: 20674601
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
